Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca2+ signaling in Huntington’s disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Acta Neuropathologica

• Publication date

  2013-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00401-013-1103-zPMID 23455440PMCID PMC3633717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fast and SNP-tolerant detection of complex variants and splicing in short reads

  2010cited by this paper
• The UCSC Genome Browser database: update 2011

  2010cited by this paper
• Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease*

  2008cited by this paper
• Model-based Analysis of ChIP-Seq (MACS)

  2008cited by this paper
• Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation.

  2008cited by this paper
• Mapping and quantifying mammalian transcriptomes by RNA-Seq

  2008influential reference
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Modulation of nucleosome dynamics in Huntington's disease.

  2007influential reference
• Pathway mapping tools for analysis of high content data.

  2007cited by this paper
• Heterochromatin revisited

  2007cited by this paper
• Re-emergence of striatal cholinergic interneurons in movement disorders.

  2007cited by this paper
• Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells

  2006cited by this paper
• Uncoupling global and fine-tuning replication timing determinants for mouse pericentric heterochromatin

  2006cited by this paper
• Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.

  2006cited by this paper
• Exploration of biological network centralities with CentiBiN

  2006cited by this paper
• Mechanisms of Disease: histone modifications in Huntington's disease

  2006cited by this paper
• Striatal D2 receptors and LTD: yes, but not where you thought they were.

  2006cited by this paper
• ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease

  2006influential reference
• Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons.

  2005cited by this paper
• Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease*

  2005cited by this paper
• Differential subnuclear localization and replication timing of histone H3 lysine 9 methylation states.

  2005cited by this paper
• Linking the epigenetic ‘language’ of covalent histone modifications to cancer

  2004cited by this paper
• mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression.

  2003cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor

  2002cited by this paper
• SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.

  2002cited by this paper
• Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases.

  2001cited by this paper
• Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails.

  2001cited by this paper
• Acetylcholine-mediated modulation of striatal function.

  2000cited by this paper
• Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.

  2000cited by this paper
• Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.

  1998cited by this paper
• Molecular biology of muscarinic acetylcholine receptors.

  1996cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain.

  1991cited by this paper
• Muscarinic receptor subtypes.

  1990cited by this paper
• Identification of a family of muscarinic acetylcholine receptor genes.

  1987cited by this paper

• Huntingtin reduction results in altered nuclear structure and heterochromatic instability

  2025cites this paper
• Bioinformatics and next generation sequencing data analysis to identify key genes and pathways influencing in Parkinson's disease

  2025cites this paper
• Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer’s Disease: A Metabolomic and Proteomic Approach

  2025cites this paper
• Editorial: Proteins and protein-complexes underlying mitochondrial structure-function and metabolism: implications in diseases

  2024cites this paper
• Loss of cholinergic receptor muscarinic 1 impairs cortical mitochondrial structure and function: implications in Alzheimer’s disease

  2023cites this paper
• Screening of the Key Genes and Signaling Pathways for Schizophrenia Using Bioinformatics and Next Generation Sequencing Data Analysis

  2023cites this paper
• Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease

  2022cites this paper
• Network toxicology and molecular docking analyses on strychnine indicate CHRM1 is a potential neurotoxic target

  2022cites this paper
• The Role of H3K4me3 in Transcriptional Regulation Is Altered in The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease Huntington's Disease how document you.

  2022cites this paper
• Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington’s disease mouse model

  2021cites this paper
• Magnolol upregulates CHRM1 to attenuate Amyloid-β-triggered neuronal injury through regulating the cAMP/PKA/CREB pathway

  2021cites this paper
• Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer’s Disease

  2021cites this paper
• Breast cancer: Muscarinic receptors as new targets for tumor therapy

  2021cites this paper
• Epigenetic regulation in Huntington's disease.

  2021cites this paper
• Epigenetics and cognitive disorders

  2021cites this paper
• Alterations of transcriptome signatures in head trauma-related neurodegenerative disorders

  2020cites this paper
• Epigenome signatures landscaped by histone H3K9me3 are associated with the synaptic dysfunction in Alzheimer's disease

  2020cites this paper
• Altered Huntingtin-Chromatin Interactions Predict Transcriptional and Epigenetic Changes in Huntington’s Disease Mouse Models

  2020cites this paper
• Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses

  2020cites this paper
• Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer’s Disease

  2020cites this paper
• Pro ling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer’s Disease

  2020cites this paper
• Early impairment of epigenetic pattern in neurodegeneration: Additional mechanisms behind pyrethroid toxicity.

  2019cites this paper
• Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington’s Disease Monkey pluripotent stem cells

  2019cites this paper
• Neuroepigenetics of Aging and Age-Related Neurodegenerative Disorders.

  2018cites this paper
• Epigenetic profiles in polyglutamine disorders.

  2018cites this paper
• Epigenetics of Huntington's Disease.

  2017cites this paper
• Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy

  2017cites this paper
• Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington’s disease

  2017cites this paper
• Genome-Wide Epigenetic Studies in Neurologic Diseases

  2016cites this paper
• Histone H3K9 methylation is dispensable for Caenorhabditis elegans development but suppresses RNA:DNA hybrid-associated repeat instability

  2016cites this paper
• Chromatin Landscape and Epigenetic Signatures in Neurological Disorders: Emerging Perspectives for Biological and Clinical Research

  2016cites this paper
• Implication of Epigenetic Modifications in Neurodegenerative Disorders:Traces and Imprints

  2016cites this paper
• The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington’s Disease

  2015cites this paper
• The epigenetics of aging and neurodegeneration.

  2015cites this paper
• CR 6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer ' s disease

  2015cites this paper
• Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis

  2015cites this paper
• Epigenetics and Triplet-Repeat Neurological Diseases

  2015cites this paper
• Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease.

  2015cites this paper
• Role of 5-hydroxymethylcytosine in neurodegeneration.

  2015cites this paper
• Melatonin Reduces Projection Neuronal Injury Induced by 3-Nitropropionic Acid in the Rat Striatum

  2014cites this paper
• Epigenetic Mechanisms of Rubinstein–Taybi Syndrome

  2014cites this paper
• Lysine (K)-deacetylase inhibitors: the real next step to neuropsychiatric and neurodegenerative disorders?

  2014cites this paper
• Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease

  2014cites this paper
• Transcription, Epigenetics and Ameliorative Strategies in Huntington’s Disease: a Genome-Wide Perspective

  2014influential citation
• What's wrong with epigenetics in Huntington's disease?

  2014influential citation
• CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease

  2014cites this paper
• Review Lysine (K)-deacetylase inhibitors: the real next step to neuropsychiatric and neurodegenerative disorders?

  2014cites this paper
• Nucleolar dysfunction in Huntington's disease.

  2014cites this paper
• Comparative proteomic analysis of histone post-translational modifications upon ischemia/reperfusion-induced retinal injury.

  2014cites this paper
• Epigenetic modifications in trinucleotide repeat diseases.

  2013cites this paper
• Reassessment of the Role of the Central Cholinergic System

  2013cites this paper
• Epigenetic Mechanisms of Neurodegeneration in Huntington’s Disease

  2013influential citation